An ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS-MS) method was developed and validated for the simultaneous determination of Ag. tetrahydrocannabinol (THC), 11-hydroxy-A%tetrahydrocannabinol (11 -OH-THC), and 11-nor-9-carboxy-A%tetrahydrocannabinol (THC-COOH) in whole blood. Samples were prepared by protein precipitation followed by solid-phase extraction. Data were acquired using positive electrospray ionization and multiple reaction monitoring. Two Deuterated analogues of each analyte were used as internal standards for quantification. Run time was 10 rain. Limits of quantification (LOQ) were 0.05 ng/mL for THC, 0.1 ng/mL for 11-OH-THC, and 0.2 ng/ml, for THC-COOH. Linearity was established from LOQ to 50 ng/mL for each substance (F always > 0.999). Accuracy ranged from 96 to 106%, and imprecision was less than 10% for all analytes. The UPLC-MS-MS method was found to be sensitive, specific, and rapid because it requires no derivatization step. It can be an alternative to gas chromatography-mass spectrometry for the determination of cannabinoids in whole blood.
Introduction
In several countries, driving under the influence of drugs has become a major concern for authorities involved in road safety. In France, cannabis is often detected in the blood samples of drivers and is considered as a major causative factor in road crashes after alcohol (1) . Cannabis may be also implicated in forensic cases and workplace accidents.
Recent use of cannabis is assessed by the detection of Ag_ tetrahydrocannabinol (THC), the major psychoactive constituent of Cannabis sativa, as well as its main metabolites 11-hydroxy-Ag-tetrahydrocannabinol (11-OH-THC) and 11-
Materials and Methods

Chemicals
Drug standards THC, ll-OH-THC, THC-COOH at concentrations of 1 mg/mL and their deuterated internal standards THC-d3, 11-OH-THC-d3, and THC-COOH-d3 at concentrations of 100 pg/mL were purchased from Promochem (Molsheim, France).
HPLC-grade acetonitrile (ACN) and ethyl acetate were obtained from Merck (Darmstadt, Germany). Formic acid (HCOOH), orthophosphoric acid, HPLC-grade methanol (MeOH), and n-hexane were purchased from Prolabo (Fontenay-sous-bois, France). Bond Elut Certify TM (3 mL, 130 rag) solid-phase extraction columns were from Varian (Les Ulis, France). Water was purified by a Milli-Q system obtained from Millipore (Molsheim, France). ng/mL for THC, 0.5 ng/mL for l l-OH-THC, and 7.1 ng/mL for THC-COOH.
Calibration standards, internal standards, and quality controls Stock solutions containing THC, 11-OH-THC, and THC-COOH (1, 10, 100, and 1000 ng/mL) were prepared by diluting the reference solutions in MeOH. The internal standard solutions were diluted in MeOH to obtain a concentration of 1 pg/mL of each species. These solutions were refrigerated at 4~ until use and found to be stable after at least 6 months in the dark.
Calibration standards were prepared in whole blood taken from healthy, drug-free volunteers and from deceased subjects. Blood from living subjects was taken by venopuncture from members of our laboratory associated to the study, using lithium-heparinate glass vials. Blood from deceased subjects was taken during necropsies performed in our pathology ward, and was stored in polypropylen vials without preservative. All blood samples were previously tested negative for cannabis by Elisa immunoassay. Calibration standards were prepared at concentrations ranging from 0.05 to 50 ng/mL.
To determine accuracy and intra-and interassay precision, quality controls were prepared by fortifying whole blood at concentrations of 0.5, 2, and 20 ng/mL with the analytes tested.
Sample extraction
A blood protein precipitation was realized before the solidphase extraction. One milliliter of whole blood was transfered to a borosilicate tube in the presence of 20 ng of THC-d3, 11-OH-THC-d3, and THC-COOH-d3. One milliliter ACN was added. The tube was vortex mixed for 30 s and centrifuged for 10 rain at 3000 x g. The supernatant was decanted to another tube, and 1 mL of 50 mM phosphoric acid was added before extraction.
The pursuit of the extraction procedure was similar to that developed by Teixeira et al. (17) .
Bond Elut Certify columns were conditioned with 2 rnL MeOH and 2 mL 50 mM phosphoric acid. After loading the prepared samples, columns were washed successively with 2 mL 50 mM phosphoric acid and 2 mL 50 mM phosphoric acid/MeOH (80:20, v/v).
The columns were allowed to dry for 5 rain. Analytes were then eluted with 1 mL nhexane, then 1 mL n-hexane/ethyl acetate (80:20). The extract was evaporated to dryness under nitrogen at 45~ and reconstituted in 50 pL ACN/0.1% HCOOH (50:50, v/v).
Ten microliters of this mixture was injected into the UPLC-MS-MS system.
Instruments
A Waters Acquity UPLC system (Milford, MA) with a column heater, autosampler, and a 10-pL injection loop was used. Analytes were separated at 45~ on a Waters Acquity UPLC BEH C18 column (1.7 pro, 100 x 2.l-ram i.d.) Separation was achieved using a gradient elution with 0.1% HCOOH (pH 2.6) and ACN at a flow rate of 0.7 mL/min (Table I) .
The total run time was 10 rain, including periods required for injection and equilibrating the column before next injection. Detection was performed using a Quattro Premier XE tandem MS (Waters-Micromass, Manchester, U.K.) equipped with an electrospray ionization probe and operated in the positive ionization mode.
The capillary voltage was set to 2.5 kV, the ion source temperature was 150~ and the desolvation gas was heated to 450~ at a flow rate of 1100 L/h. The cone gas was set to 100 L/h, and collision gas (argon) pressure was maintained at 4 mbar.
Multiple reaction monitoring (MRM) was employed to detect quantification and confirmation ions listed in Table II . Data acquisitions were done using Masslynx | 4.1 software (Waters).
(0.5, 2, and 20 ng/mL; n = 6), and analyzed (B). The peak areas were compared to directly injected standards at the same concentrations (A). Matrix effect was calculated using the formula: ME % = B/A x 100.
Matrix effect values of 100% indicated no matrix effect, values < 100% indicated ion suppression, and values > 100% indicated ion enhancement.
Stability was tested to measure degradation of the analytes in whole blood, by using quality controls at 2 ng/mL (n = 4). Nonsilanized glasses were used for this study. Temperature effect was examined for samples stored at room temperature, +4, and -20~ one day and one week later. Freeze-thaw stability was also determined after three freeze-thaw cycles at 24-h intervals.
Method validation
The method was validated with the following criteria: limit of detection (LOD), limit of quantification (LOQ), linearity, recovery, accuracy, intra-and interassay precision, stability, and matrix effect. Statistical procedures were performed using Microsoft Excel.
Method validation was carried out with six analytical runs on five consecutive days.
LOD and LOQ were determined by assaying a series of decreasing concentrations of cannabinoids in whole blood. LOD was defined as the lowest concentration where the signal of the compound was equivalent to three times the background noise, and LOQ was defined as the lowest concentration with a signal-to-noise of 10:1 and a coefficient of variation not greater than 20%.
Linearity was tested by the preparation of calibration curves that ranged from LOQ to 50 ng/mL for each analyte. A series of three curves was prepared with nine concentrations for THC (0.05, 0.I, 0.2, 0.5, i, 2, 10, 20, and 50 ng/mL), eight concentrations for 11-OH-THC, and seven concentrations for THC-COOH.
Linearity of the method was investigated by calculation of the regression line by the method of least squares and expressed by the correlation coefficient (r~).
The extraction recovery was determined by comparing the peak areas of blank extracted samples spiked before extraction with the peak area of blank samples spiked after the extraction procedure. Three levels of THC, 1 I-OH-THC, and THC-COOH concentrations < (0.5, 2, and 20 ng/mL) were tested.
Intra-and interassay precision and accuracy were evaluated using three quality controls (0.5, 2, and 20 ng/mL). Precision was expressed as the coefficient of variation (CV %), and accuracy was expressed as the percentage of deviation between nominal and measured concentrations.
Matrix effect was evaluated using the method described by Matuszewski et al. (18) . Blank whole blood was extracted, fortified with ana]ytes at three different concentrations
Results
In UPLC conditions, the retention times were 6.30 _+ 0.05 rain for THC, 4.25 + 0.07 rain for 11-OH-THC, and 4.52 + 0.07 rain for THC-COOH (Figure 1 ). The use ofa bilineary gra- dient allowed a better resolution between 11-OH-THC and THC-COOH which display very similar chromatographic behaviors, followed by a rapid elution of THC. LODs, LOQs, and linearity are presented in Table III . The same results were obtained with blood from living subjects as well as from deceased ones. The calibration curves showed good linear response (r ~ > 0.999) over the range from 0.05 to 50 ng/mL for THC; 0.1 to 50 ng/mL for 11-OH-THC and 0.2 to 50 ng/mL for THC-COOH using a 1/x 2 weighting factor. LOQs in whole blood were 0.05 ng/mL ( CV < 7.3%), 0.1 ng/mL (CV < 8.1%), and 0.2 ng/mL (CV < 8.9%), respectively (Figure 2) . LODs ranged from 0.02 ng/mL to 0.1 ng/mL. Table IV shows the recovery and matrix effect tested at three different concentrations (0.5, 2, and 20 ng/mL; n ---6) in whole blood for each analytes. The extraction recoveries were > 47% for THC, > 64% for 11-OH-THC, and > 56% for THC-COOH. Under these conditions, low recoveries were counterbalanced by the great sensitivity of detector. No signifiant matrix effect was observed in whole blood tested. Accuracy and intra-and interassay precision of the method were determined by analyzing replicate (n = 6) whole blood samples, containing analytes of interest at concentrations of 0.5, 2, and 20 ng/mL, in the same day and on five consecutive days.The interassay values were based on five batches of n = 6 each. The results of these analyses are summarized in Table V. [ntra-and interassay precision calculated from repeated analyses was < 10% for all analytes. Accuracy ranged from 96.5% to 105.9% for the three compounds at all concentrations.
THC, 11-OH-THC, and THC-COOH were found stable (< 6% variability) for 24 h at room.temperature, +4, and -20~ For evaluation of freeze-thaw stability, QC samples (n = 4) were analyzed after three freeze-thaw cycles. For each cycle, the samples were frozen at -20~ for 20 h, thawed, and then kept at ambient temperature for 4 h. Results show only poor variation due to thawing of the samples (4% variability). After seven days, the analytes were found stable at +4 and -20~ but at room tempera- (Table VI) . Deuterated standards in methanolic solu-90.5 3.2
Lion were tested to assess any degradation in 93.6 2.9 nondeuterated ions. The reference solutions 95.8 2.2 from the manufacturer were performed once of the beginning our experiment. Nonex-88.1 5.1 tracted 20 ng/mL deuterated standards were 9o.7 3. 8 injected, and a ratio between deuterated ions 93.9 3.3 and nondeuterated ions presents was calculated. No degradation was observed for 11-OH-THC-d3 and THC-COOH-d3. The presence of THC was observed in THC-d3 internal standard at a level of 0.04%, which represents 0.008 ng/mL in methanolic solution. This poor formation of THC is not significant because of our LOD (0.02 ng/mL), 
Discussion
Based on the extraction procedure described by Teixeira et al. (17) , a new UPLC-MS-MS method was developed for the determination of THC and metabolites in whole blood. This relatively simple method allowed us to reach LOQs as low as 0.05 ng/mL for THC, 0.1 ng/mL for 11-OH-THC, and 0.2 ng/mL for THC-COOH. These LOQs are much lower than those achieved by classical GC-MS, HPLC-MS, or HPLC-MS-MS methods. Previous LOQs obtained with our References routine GC-MS method (19) were 1.0 ng/mL, 0.5 ng/mL, and 0.5 ng/mL, respectively (2 mL blood used). Other GC-MS procedures reported in the literature display LOQs ranging from 0.5 to 1.0 ng/mL for THC (3,4,6,7). The LC-MS method developed by Teixeira et al. (8) showed LOQs of 2.0 ng/mL for both THC and THC-COOH. Using LC-MS-MS, LOQs of 0.8 ng/mL for THC and 11-OH-THC, and 4.3 ng/mL for THC-COOH were reported by Maralikova et al. (14) , and LOQs of 0.2 ng/mL for all three componds by Grauwiller et al. (9) . Both studies were performed on plasma samples.
Another advantage of UPLC-MS-MS is its ability to reduce extraction time, since this step requires no silanization or derivatization procedures. In addition the total chromatographic time (including injection, gradient, and post-run, requilibration column) was only 10 rain, compared to at least 20 min with conventional GC-MS methods.
Finally, this method offers an interesting compromise between simplicity, rapidity, and high level of sensitivity, making it particularly suitable when unequivocal determination of cannabinoids should be obtained in a short period of time.
9.
Conclusions
A sensitive, specific, and rapid UPLC-MS-MS method to simultaneously quantify THC, 11-OH-THC, and THC-COOH in whole blood was developed and validated as an alternative to GC-MS, which was the reference method previously used in our laboratory.
The sample preparation time is decreased by eliminating derivatization step, and the total analysis time was less than 2 h for one sample. This method can be a great interest when urgent determination of cannabinoids is needed (e.g., legal concerns following road accidents).
